Bruker today announces the North American launch of its compact, fully automated and fast toxinentification system, called pTD® (portable Toxin Detector), at the American Society for Microbiology (ASM) Bio-Defense and Emerging Diseases Research Meeting in Washington, DC. The novel, benchtop, push-button pTD system is intended for smaller, field and mobile laboratories for use by non-expert operators in homeland security applications.

While detection capabilities for bacterial or viral agents exist, using either PCR-based or proteomic fingerprintingentification (e.g. Bruker MALDI Biotyper), the current technologies for the detection andentification of toxins in the field are insensitive and slow, or involve complicated sample preparation in specialized laboratories. The unique, new Bruker pTD system greatly simplifies and accelerates the process of detecting a potential biological terror attack using toxins. The pTD system uses a novel, lab chip-based, fully automated ELISA process that allows the simultaneousentification of five toxins with an order of magnitude better sensitivity than traditional techniques. The fully automated pTD includes controls to minimize false positive or negative alarms ˆ with toxinentification and quality control all in less than 30 minutes.

The pTD system accepts liquid and solid samples and does not require any external sample preparation steps. Every sample is automatically checked for five toxins simultaneously using multiplexed, proprietary lab chips. Toxinentification is based on ELISA assays using highly specific antibodies, combined with an electrochemical readout. All sample preparation steps are performed automatically inside the lab chip, and the results are displayed on the control computer. Before shutdown, the system automatically decontaminates itself internally.

The pTD system, which has been co-developed with Analytik Jena AG, presentlyentifies the five toxins Botulinum Toxin A, B and E, as well as Ricin and Staphylococcus enterotoxin B on one chip. Additional toxin chips are under development.

Frank Thibodeau, Vice President of Bruker Detection Corporation, stated: “Unfortunately, compared to the complexity of producing and using bacteria or viruses for terror attacks, toxins are potentially easier to produce and can be a serious threat. With the increasing threat by toxins, the easy to use, fully automated, fast, very sensitive and fieldable pTD system is vital for homeland security and defense applications.”

About Bruker Detection Corporation Bruker Detection is a leading provider of a broad range of ruggedized, field analytical systems for chemical, biological, radiological, nuclear and explosives (CBRNE) detection. For more information on Bruker Detection Corporation and Bruker Corporation (NASDAQ: BRKR), please visit www.bruker.com

Bruker Cautionary Statement Any statements contained in this presentation that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, risks and uncertainties relating to adverse changes in conditions in the global economy and volatility in the capital markets, the integration of businesses we have acquired or may acquire in the future, changing technologies, product development and market acceptance of our products, the cost and pricing of our products, manufacturing, competition, dependence on collaborative partners and key suppliers, capital spending and government funding policies, changes in governmental regulations, realization of anticipated benefits from economic stimulus programs, intellectual property rights, litigation, and exposure to foreign currency fluctuations and other risk factors discussed from time to time in our filings with the Securities and Exchange Commission. These and other factors areentified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2009, our most recent quarterly reports on Form 10-Q and our current reports on Form 8-K. We expressly disclaim any intent or obligation to update these forward-looking statements other than as required by law.

For more information, contact: Frank Thibodeau Vice President, Business Development Phone: 1-978-663-3660 x1308 Email: fnt@bdal.com